Inj. lorazepam IM

Reading File
Lorazepam IM is a benzodiazepine used for acute seizures, sedation, and agitation. Let me pull the full clinical details from the textbook library.
Searching sources...
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Here is a comprehensive clinical summary of Injection Lorazepam IM:

Inj. Lorazepam IM (Ativan)

Drug Class & Mechanism

Lorazepam is a benzodiazepine that enhances the effect of gamma-aminobutyric acid (GABA) at the GABA-A receptor, increasing chloride ion conductance and producing CNS depression. It exerts anxiolytic, sedative, anticonvulsant, and muscle-relaxant effects.

Pharmacokinetics (IM Route)

ParameterLorazepam
Absorption (IM)Well absorbed; reliable
Peak plasma level (IM)~90 min
Protein binding90-98%
Lipid solubilityModerate (accounts for slower brain uptake vs. midazolam)
Elimination half-life~15 h
MetabolismHepatic glucuronidation (no active metabolites)
ExcretionUrine
Note: Diazepam IM is painful and unreliably absorbed - lorazepam IM is preferred when IV access is unavailable. Midazolam peaks faster (30 min IM).
  • Morgan & Mikhail's Clinical Anesthesiology, 7e

Indications for IM Use

1. Acute Agitation / Psychiatric Emergency

  • Monotherapy: 2-4 mg IM - equivalent efficacy to haloperidol 5 mg
  • Combination (most common): Haloperidol 5 mg + Lorazepam 2 mg IM - produces faster sedation than either agent alone; this is the classic "B52" or similar combination used in psychiatric emergencies
  • American College of Emergency Physicians: Level B recommendation supports monotherapy with lorazepam for acute agitation
  • Useful across diagnoses: mania, schizophrenia, delirium, substance-induced states

2. Status Epilepticus (when IV access unavailable)

  • Lorazepam is the most effective benzodiazepine for status epilepticus and treatment of choice for acute seizure control (Harrison's, 2025)
  • IV preferred; IM can be used when IV not available
  • Dose: 0.1 mg/kg IV (max 4 mg); repeat in 5 min if needed - Rosen's Emergency Medicine
  • For SE in adults: 2-4 mg/min IV to total 10-15 mg - Adams & Victor's Neurology
  • Always follow with a maintenance anticonvulsant: fosphenytoin, valproate, or levetiracetam

3. Alcohol Withdrawal Seizures

  • Lorazepam 2 mg IV/IM; may need repeated doses
  • Preferred in liver disease patients (no active metabolites)

4. Preoperative Premedication

  • 0.05 mg/kg orally; IM route also used

5. Neuroleptic Malignant Syndrome (NMS)

  • IM lorazepam has been used as adjunctive management after antipsychotic withdrawal
  • Maudsley Prescribing Guidelines, 15e

Dosage Summary

IndicationDoseRoute
Acute agitation (monotherapy)2-4 mgIM
Acute agitation (with antipsychotic)2 mgIM
Status epilepticus0.1 mg/kg (max 4 mg), repeat once if neededIV preferred; IM if no IV
Alcohol withdrawal seizure2 mgIV/IM
Premedication0.05 mg/kgOral/IM
Delirium (as adjunct)0.5-5 mgIM

Adverse Effects

SystemEffect
RespiratoryDose-dependent respiratory depression; apnea possible (esp. with IV/opioid co-administration)
CNSExcessive sedation, anterograde amnesia, ataxia
CardiovascularMild BP/CO reduction; hypotension (more with opioid combination)
ParadoxicalDisinhibition, agitation (rare)
DeliriumCan worsen delirium (use with caution in non-alcohol delirium)
Ventilation must be monitored in all patients receiving benzodiazepines IV; resuscitation equipment and airway-trained personnel must be present.
  • Morgan & Mikhail's Clinical Anesthesiology, 7e

Contraindications / Precautions

  • Absolute: Acute narrow-angle glaucoma, severe respiratory insufficiency (unless intubated), hypersensitivity to benzodiazepines
  • Caution: Hepatic impairment (dose reduction), elderly (prolonged effect), co-administration with opioids or other CNS depressants (synergistic respiratory depression)
  • Pregnancy: Use minimal effective dose; avoid if possible
  • COPD / Obstructive sleep apnea: High risk of respiratory depression

Drug Interactions

  • Opioids: Marked synergistic respiratory depression and hypotension
  • CNS depressants (alcohol, barbiturates, antipsychotics): Additive sedation
  • Cimetidine: Inhibits hepatic metabolism, prolongs effect
  • Volatile anesthetics: Lorazepam reduces minimum alveolar concentration by up to 30%

Reversal

  • Flumazenil (competitive benzodiazepine antagonist): reverses sedation and respiratory depression
  • Caution: short duration of action (may need repeated doses); can precipitate withdrawal seizures in chronic users
  • Miller's Anesthesia, 10e

Key Clinical Points

  1. Lorazepam IM is reliably absorbed - unlike diazepam IM
  2. Onset slower than midazolam IM (90 min vs. 30 min peak) - prefer midazolam if very rapid effect needed
  3. No active metabolites - safer in liver disease than diazepam
  4. Clinical duration is often prolonged despite moderate half-life, due to high receptor affinity
  5. For status epilepticus, always follow with a long-acting anticonvulsant (fosphenytoin, VPA, levetiracetam)
  6. In delirium, benzodiazepines can worsen cognitive dysfunction - dexmedetomidine preferred for non-alcohol/non-withdrawal ICU delirium
This is a shared conversation. Sign in to Orris to start your own chat.